Cargando…

P1699: ANTITHROMBIN DEFICIENCY IS ASSOCIATED WITH PROTHROMBOTIC FIBRIN CLOT PHENOTYPE

Detalles Bibliográficos
Autores principales:	Zabczyk, M., Natorska, J., Undas, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430810/ http://dx.doi.org/10.1097/01.HS9.0000849652.14725.f8

Ejemplares similares

Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype
por: Natorska, Joanna, et al.
Publicado: (2023)

Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence
por: Undas, Anetta
Publicado: (2017)

Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2018)

Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia
por: Nowakowski, Tomasz, et al.
Publicado: (2019)

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation
por: Ząbczyk, Michał, et al.
Publicado: (2023)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis
por: Sobczak, Amélie I. S., et al.
Publicado: (2020)

Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
por: Kupis, Robert W., et al.
Publicado: (2019)

Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations
por: Winiarska, Aleksandra, et al.
Publicado: (2019)

Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation
por: Gajos, Grzegorz, et al.
Publicado: (2018)

Erythrocyte compression index is impaired in patients with residual vein obstruction
por: Zabczyk, Michal, et al.
Publicado: (2018)

Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency
por: Bezuidenhout, Johannes A., et al.
Publicado: (2020)

Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study
por: Polak, Maciej Wiktor, et al.
Publicado: (2019)

Fibrin structure in organized thrombotic material removed during pulmonary artery endarterectormy: the effect of vessel calibre
por: Mazur, Piotr, et al.
Publicado: (2016)

Increased Plasma Clot Permeability and Susceptibility to Lysis Are Associated with Heavy Menstrual Bleeding of Unknown Cause: A Case-Control Study
por: Szczepaniak, Piotr, et al.
Publicado: (2015)

Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification
por: Kopytek, Magdalena, et al.
Publicado: (2021)

Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes
por: Kopytek, Magdalena, et al.
Publicado: (2020)

Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
por: Piróg, Magdalena, et al.
Publicado: (2019)

Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein
por: Szułdrzyński, Konstanty, et al.
Publicado: (2020)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Endotoxin enhances the fibrinolytic activity of monocytes incorporated in a fibrin clot
por: Grosjean, A, et al.
Publicado: (2005)

Towards Personalized Therapy of Aortic Stenosis
por: Mazur, Piotr, et al.
Publicado: (2021)

PAI-1 Overexpression in Valvular Interstitial Cells Contributes to Hypofibrinolysis in Aortic Stenosis
por: Kopytek, Magdalena, et al.
Publicado: (2023)

Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Unfavourably altered plasma clot properties in patients with primary Raynaud’s phenomenon: association with venous thromboembolism
por: Żuk, Joanna, et al.
Publicado: (2019)

The Background and Purpose of Garth's Dispensary (1699)
por: Roberts, P. E.
Publicado: (1968)

Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
por: Bochenek, Maciej, et al.
Publicado: (2012)

P1693: THROMBOMODULIN RESISTANCE: A NEW PROTHROMBOTIC PATHWAY IN COVID-19
por: Montaño, A., et al.
Publicado: (2022)

Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties
por: Skuza, Anna Aleksandra, et al.
Publicado: (2018)

Prothrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood
por: Bazan-Socha, Stanislawa, et al.
Publicado: (2017)

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008)

P1643: FIBRIN CLOT PROPERTIES IDENTIFY PATIENTS THAT BENEFIT FROM CATHETER-DIRECTED THROMBOLYSIS: A POST HOC ANALYSIS OF THE CAVA TRIAL
por: Iding, Aaron F.J., et al.
Publicado: (2023)

Properties of Plasma Clots in Adult Patients Following Fontan Procedure: Relation to Clot Permeability and Lysis Time—Multicenter Study
por: Skubera, Maciej, et al.
Publicado: (2021)

P1656: PROGRESSIVE WORSENING OF PROTHROMBOTIC PROFILE IN PATIENTS WITH AGGRESSIVE LYMPHOMA ON CHEMOTHERAPY
por: Jaime, Francisco José López, et al.
Publicado: (2023)

P1671: GENES POLYMORPHISM OF THROMBOPHILIA AND PROTHROMBOTIC CONDITIONS IN WOMEN WITH VARIOUS OBSTETRIC ANAMNESIS
por: Zagarskikh, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4ljj7268t0jenb3fkti6q0joj